These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2004-000984-81||A PHASE III PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER, TOLERANCE AND EFFICACY STUDY OF RSD1235 IN SUBJECTS WITH ATRIAL FIBRILLATION OR ATRIAL FLUTTER||2005-07-30||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2005-004195-20||A Phase 3, Multi-Center, Open Label Safety Study of RSD1235 in Subjects with Atrial Fibrillation.||2007-01-03||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2005-004713-15||A Pilot Phase II, Randomised, Double-blind, Placebo-controlled, Multi-centred Safety, Tolerability and Preliminary Efficacy Study of RSD1235-SR for the Prevention of Atrial Fibrillation/Atrial Flutter...||2006-08-17||bad-data|
|Listed as ongoing, but also has a completion date||2006-005072-40||Vernakalant (oral) Prevention of Atrial Fbrillation Recurrence Post-Conversion Study||2008-07-04||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2007-005625-29||A Phase III Prospective, Randomized, Double-Blind, Active-Controlled, Multi-Center, Superiority Study of Vernakalant Injection versus Amiodarone in Subjects with Recent Onset Atrial Fibrillation||2009-11-23||bad-data|
|Not reported||2010-018374-20||A Phase 3b Randomized, Double-Blind, Placebo Controlled, Parallel Group Study to Evaluate the Safety and Efficacy of Vernakalant Hydrochloride Injection in Patients with Recent Onset Symptomatic Atria...||2012-02-20||due-trials|